Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 8 filers reported holding Novozymes A/S in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $274,000 | -21.3% | 6,225 | -14.7% | 0.18% | -25.4% |
| Q2 2016 | $348,000 | -4.4% | 7,300 | -9.6% | 0.24% | -5.1% |
| Q1 2016 | $364,000 | -12.7% | 8,075 | -6.9% | 0.25% | -13.9% |
| Q4 2015 | $417,000 | -10.1% | 8,675 | -18.5% | 0.29% | +4.6% |
| Q3 2015 | $464,000 | -6.3% | 10,650 | +2.2% | 0.28% | +7.3% |
| Q2 2015 | $495,000 | +3.8% | 10,425 | 0.0% | 0.26% | +7.4% |
| Q1 2015 | $477,000 | +10.4% | 10,425 | +2.0% | 0.24% | +2.1% |
| Q4 2014 | $432,000 | -16.1% | 10,225 | -13.8% | 0.24% | -27.1% |
| Q3 2014 | $515,000 | -25.9% | 11,860 | -14.4% | 0.33% | -31.8% |
| Q2 2014 | $695,000 | -43.7% | 13,860 | -50.6% | 0.48% | -46.3% |
| Q1 2014 | $1,235,000 | -5.4% | 28,075 | -9.1% | 0.90% | -14.2% |
| Q4 2013 | $1,306,000 | +211.0% | 30,885 | +181.8% | 1.04% | +171.9% |
| Q3 2013 | $420,000 | +4.2% | 10,960 | -13.0% | 0.38% | -0.8% |
| Q2 2013 | $403,000 | – | 12,595 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lenox Wealth Management, Inc. | 70,039 | $3,834,000 | 1.14% |
| GARRISON BRADFORD & ASSOCIATES INC | 15,100 | $827,000 | 0.67% |
| Moloney Securities Asset Management, LLC | 31,722 | $1,742,000 | 0.60% |
| ZEVIN ASSET MANAGEMENT LLC | 34,729 | $1,901,000 | 0.56% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 6,490 | $356,000 | 0.48% |
| BOSTON FINANCIAL MANGEMENT LLC | 102,687 | $5,621,000 | 0.33% |
| Boston Common Asset Management, LLC | 18,656 | $1,025,000 | 0.13% |
| Hemenway Trust Co LLC | 12,000 | $657,000 | 0.11% |
| QUADRANT CAPITAL GROUP LLC | 2,011 | $104,000 | 0.03% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 261,819 | $14,332,000 | 0.01% |